Andrew Frankart received a five-year, $729,000 American Cancer Society/American Society for Radiation Oncology Clinician Scientist Development Grant to lead a clinical trial at the University of Cincinnati Cancer Center that will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.
The American Cancer Society’s recent report on the increasing incidence rates of colorectal cancer in young adults once again rang an alarm bell for adults over 45 to get checked, especially if they are having symptoms. But as an oncologist with more than 40 years of experience, I also believe that this should be a clarion call to scientists and researchers, and for regulators at the FDA.
